Rozenkier v. AG Schering

196 F. App'x 93
CourtCourt of Appeals for the Third Circuit
DecidedAugust 2, 2006
Docket04-3934
StatusUnpublished
Cited by3 cases

This text of 196 F. App'x 93 (Rozenkier v. AG Schering) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rozenkier v. AG Schering, 196 F. App'x 93 (3d Cir. 2006).

Opinion

OPINION OF THE COURT

LOURIE, Circuit Judge.

Simon Rozenkier appeals from the decision of the United States District Court for the District of New Jersey granting Schering AG’s and Bayer AG’s (the “Appellees”) motion to dismiss Rozenkier’s complaint for failure to state a claim pursuant to Federal Rule of Civil Procedure 12(b)(6). In re Nazi Era Cases Against German Defendants Litigation, 334 F.Supp.2d 690 (D.N.J.2004) (“Decision”). Because Rozenkier’s claims are nonjusticiable under the political question doctrine, we affirm.

I. BACKGROUND

This case arises from the horrific, widespread crimes perpetrated by the Nazi government during World War II. Rozenkier, a Holocaust survivor, was subjected to inhumane Nazi medical experimentation while he was imprisoned at the AuschwitzBirkenau concentration camps. Decision, 334 F.Supp.2d at 691. During his internment in 1944, he was forced to undergo injections of unknown chemical substances into his testicles causing swelling and bleeding of his genitalia. Id. After his liberation from Auschwitz-Birkenau, Rozenkier emigrated from Poland to the United States. Id. In 1952, he married but was unable to have children. Id. The cause of his sterility remained unknown until 1999, when Rozenkier learned definitively that his “infertility was the result of a Nazi ‘medical experiment.’ ” Id.

Rozenkier’s case does not arise in isolation. In the late 1990’s, Holocaust survivors filed a number of class action lawsuits seeking compensation from German *95 corporations who allegedly participated in Nazi-era crimes arising from slave and forced labor during World War II. In 1998, at the request of the German government, the United States government agreed to facilitate the resolution of those lawsuits. Following the personal involvement of the President of the United States and German Chancellor Schroeder, the federal governments of the United States and Germany, German corporations, and attorneys for various plaintiffs agreed that the plaintiffs would voluntarily dismiss their lawsuits in exchange for the creation of the German Foundation “Remembrance, Responsibility and the Future” (the “Foundation”), which would make payments to Nazi victims from a DM 10 billion pool.

On July 17, 2000, the United States and German governments signed an agreement (the “Joint Statement”) expressing their support for the Foundation. Joint Statement, at 3. Concurrently, the two governments signed an executive agreement (the “Executive Agreement”) recognizing the desire of the two governments for an “all embracing and enduring legal peace to advance their foreign policy interests” and reflecting their commitments to the Foundation as “the exclusive remedy and forum for the resolution of ... all claims that have been or may be asserted against German companies arising from the National Socialist era and World War II,” Executive Agreement, Art. 1(1) (emphasis added), including specifically medical experimentation claims. Id. at Annex A, 114. The Executive Agreement also stated that the “United States shall ... inform its courts through a Statement of Interest ... that it would be in the foreign policy interests of the United States for the Foundation to be the exclusive remedy and forum for resolution” of those claims. Id. at Art. 2(1). Specifically, the Executive Agreement provided:

[T]he United States will timely file a Statement of Interest and accompanying foreign policy statement of the Secretary of State and Declaration of Deputy Treasury Secretary Stuart E. Eizenstat in all pending and future cases, regardless of whether the plaintiffis) consent(s) to dismissal, in which the United States is notified that a claim has been asserted against German companies arising from the National Socialist era and World Warll.

Id. at Annex B, at 1.

On August 12, 2000, after the Joint Statement and Executive Agreement were executed, the German government enacted laws for implementing the Foundation (“Foundation Law”)- The Foundation Law allocated DM 50 million for the compensation of “other personal injuries,” including injuries to victims of medical experimentation, and capped individual awards for those injuries at DM 15,000. Foundation Law, at §§ 9(1), 9(3). In a series of letters from the lead German negotiator, Otto Graf Lambsdorff, to the lead United States negotiator, Stuart Eizenstat, the German government reaffirmed that the “DM 50 million allocation [for other personal injury] will be distributed to each partner organization so that each approved applicant is provided a pro-rata amount of the total amount of all approved ‘other personal injur/ applicants” and that the “Foundation will give victims of medical experimentation and Kinderheim cases priority over other non-labor personal injury wrongs.” Letter from Lambsdorff to Eizenstat, July 11, 2000. On October 19, 2000, the United States and Germany exchanged diplomatic notes declaring the Foundation Law, as clarified by the Lambsdorrf-Eizenstat letters, to be “fully consistent” with the Executive Agreement, causing the Executive Agreement to enter into force as of that date. Exchange of Notes between the Embassy of the United *96 States and the Federal Foreign Office of Germany, Oct. 19, 2000.

In March 2001, Rozenkier applied for compensation from the Foundation for his injuries. In submitting his application, Rozenkier executed a waiver against “all German companies for claims in connection to National Socialist injustices.” The Foundation approved Rozenkier’s application by letter dated February 6, 2004, and issued him two compensation checks for $4,645.09 and $5,348.36. Decision, 334 F.Supp.2d at 694.

Notwithstanding his Foundation application, Rozenkier filed suit in the Eastern District of New York against Schering AG and Bayer AG (the “Appellees”) on March 25, 2003, alleging that the Appellees had cooperated with the Nazi regime in causing his sterilization, and claiming damages under a number of tort theories, including negligence, infliction of emotional distress, assault and battery, conspiracy, fraud, and breach of the manufacturer’s duty to warn, as well as violations of international law. Rozenkier also alleged that the waiver he had submitted with his Foundation application was void because the Foundation had unilaterally altered the compensation scheme and eliminated the right to file an appeal with the Independent Appeals Authority. In August 2003, the Judicial Panel on Multidistrict Litigation transferred the action to the United States District Court for the District of New Jersey pursuant to 28 U.S.C. § 1407, on the ground that the case raised common questions of fact with 35 previously transferred Nazi-era cases filed by American plaintiffs against German corporations.

The Appellees moved to dismiss Rozenkier’s complaint for failure to state a claim under Federal Rule of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

DHARIA v. United States
D. New Jersey, 2024
Simon v. Republic of Hungary
37 F. Supp. 3d 381 (District of Columbia, 2014)
Kerr v. Hickenlooper
880 F. Supp. 2d 1112 (D. Colorado, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
196 F. App'x 93, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rozenkier-v-ag-schering-ca3-2006.